PetVivo Holdings, Inc. (PETVW)
US — Healthcare Sector
Automate Your Wheel Strategy on PETVW
With Tiblio's Option Bot, you can configure your own wheel strategy including PETVW - and automate your put writes, covered calls, and full wheel strategy. Just connect one of the supported brokerages: tastytrade, Schwab, TradeStation or Tradier and go.
Start Your Free Trial NowKey Metrics & Ratings
- symbol PETVW
- Rev/Share 0.0463
- Book/Share -0.0337
- PB -22.8667
- Debt/Equity -3.4088
- CurrentRatio 0.4178
- ROIC -6.0438
- MktCap 18141046.0
- FreeCF/Share -0.2748
- PFCF -3.2
- PE -1.8409
- Debt/Assets 0.761
- DivYield 0
- ROE -28.0696
- Rating
- Score
- Recommendation
- P/E Score
- DCF Score
- P/B Score
- D/E Score
Recent Analyst Ratings
| Type | Ticker | Analyst Firm | Previous Rating | Current Rating | Previous Price Target | Current Price Target | Date |
|---|---|---|---|---|---|---|---|
| No ratings available. | |||||||
News
About PetVivo Holdings, Inc. (PETVW)
- IPO Date 2021-08-11
- Website http://www.petvivo.com
- Industry Medical - Devices
- CEO John Lai
- Employees 20
PetVivo Holdings, Inc., a veterinary biotech and biomedical device company, engages in the licensing and commercializing of medical devices and biomaterials for the treatment of afflictions and diseases in animals. Its lead product is Kush, a veterinarian-administered joint injection for the treatment of osteoarthritis and lameness in dogs and horses. The company's pipeline products include 17 therapeutic devices for veterinary and human clinical applications. PetVivo Holdings, Inc. is headquartered in Minneapolis, Minnesota.